Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4H5I3
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_SKI1_1 | 23 | 27 | PF00082 | 0.320 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.277 |
DOC_MAPK_gen_1 | 76 | 84 | PF00069 | 0.527 |
DOC_MAPK_gen_1 | 92 | 99 | PF00069 | 0.440 |
DOC_MAPK_MEF2A_6 | 76 | 84 | PF00069 | 0.529 |
DOC_USP7_MATH_1 | 63 | 67 | PF00917 | 0.462 |
DOC_USP7_MATH_1 | 87 | 91 | PF00917 | 0.445 |
DOC_USP7_UBL2_3 | 41 | 45 | PF12436 | 0.376 |
DOC_WW_Pin1_4 | 117 | 122 | PF00397 | 0.567 |
DOC_WW_Pin1_4 | 2 | 7 | PF00397 | 0.473 |
DOC_WW_Pin1_4 | 27 | 32 | PF00397 | 0.491 |
LIG_14-3-3_CanoR_1 | 34 | 42 | PF00244 | 0.529 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.508 |
LIG_eIF4E_1 | 20 | 26 | PF01652 | 0.535 |
LIG_FHA_1 | 35 | 41 | PF00498 | 0.386 |
LIG_FHA_1 | 6 | 12 | PF00498 | 0.426 |
LIG_LIR_Apic_2 | 2 | 6 | PF02991 | 0.483 |
LIG_LIR_Gen_1 | 120 | 129 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 120 | 126 | PF02991 | 0.489 |
LIG_LIR_Nem_3 | 27 | 32 | PF02991 | 0.490 |
LIG_LYPXL_S_1 | 94 | 98 | PF13949 | 0.524 |
LIG_LYPXL_yS_3 | 95 | 98 | PF13949 | 0.525 |
LIG_SH2_CRK | 110 | 114 | PF00017 | 0.617 |
LIG_SH2_CRK | 123 | 127 | PF00017 | 0.615 |
LIG_SH2_CRK | 52 | 56 | PF00017 | 0.431 |
LIG_SH2_SRC | 110 | 113 | PF00017 | 0.625 |
LIG_SH2_SRC | 117 | 120 | PF00017 | 0.610 |
LIG_SH2_STAT5 | 114 | 117 | PF00017 | 0.539 |
LIG_SH2_STAT5 | 12 | 15 | PF00017 | 0.463 |
LIG_SH3_3 | 106 | 112 | PF00018 | 0.548 |
LIG_SH3_3 | 115 | 121 | PF00018 | 0.508 |
LIG_SUMO_SIM_par_1 | 24 | 30 | PF11976 | 0.535 |
MOD_CDK_SPxxK_3 | 2 | 9 | PF00069 | 0.455 |
MOD_CDK_SPxxK_3 | 27 | 34 | PF00069 | 0.491 |
MOD_CK1_1 | 124 | 130 | PF00069 | 0.424 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.456 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.425 |
MOD_GlcNHglycan | 88 | 92 | PF01048 | 0.467 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.600 |
MOD_GSK3_1 | 71 | 78 | PF00069 | 0.474 |
MOD_PIKK_1 | 121 | 127 | PF00454 | 0.501 |
MOD_PKA_2 | 75 | 81 | PF00069 | 0.529 |
MOD_Plk_4 | 63 | 69 | PF00069 | 0.396 |
MOD_ProDKin_1 | 117 | 123 | PF00069 | 0.568 |
MOD_ProDKin_1 | 2 | 8 | PF00069 | 0.464 |
MOD_ProDKin_1 | 27 | 33 | PF00069 | 0.491 |
TRG_ENDOCYTIC_2 | 110 | 113 | PF00928 | 0.448 |
TRG_ENDOCYTIC_2 | 123 | 126 | PF00928 | 0.466 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.431 |
TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.504 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTR1 | Leptomonas seymouri | 86% | 99% |
A0A1X0NNG9 | Trypanosomatidae | 59% | 100% |
A0A3R7KCI5 | Trypanosoma rangeli | 56% | 100% |
A0A3S5H6A7 | Leishmania donovani | 89% | 100% |
A4HTS4 | Leishmania infantum | 89% | 100% |
D0A984 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 100% |
E9AMK7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4QI29 | Leishmania major | 87% | 100% |
V5BIJ7 | Trypanosoma cruzi | 59% | 100% |
V5BSY3 | Trypanosoma cruzi | 32% | 66% |